Branded generics are generic drugs that have been given proprietary brand names. They have a small, but profitable place in the U.S. pharmaceutical market.
The post Branded Generics: What They Are and Why They’re Profitable appeared first on DrugPatent…
Branded Generics: What They Are and Why They’re Profitable Read Post »
Kenneth L. Dorsney, Editor-in-Chief 1,035 pages Buy from Amazon Pre-ANDA litigation is the companion to ANDA Litigation, which I recommend for its guidance on all matters occuring after a drug…
The post Pre-ANDA Litigation: Strategies and Tactics for D…
Brex is the first corporate credit card specifically for biotech and pharma startups. They provide corporate cards with no founder liability, a best in class rewards program, 10-20x higher spending limits…
The post Brex: The first corporate credit card…
Brex: The first corporate credit card specifically for biotech and pharma startups Read Post »
Pharmaceutical life cycle management begins earlier and ends later to maximize stakeholder value in all phases of drug development.
The post How Pharmaceutical Life Cycle Management Strategies Are Evolving appeared first on DrugPatentWatch – Make Bette…
How Pharmaceutical Life Cycle Management Strategies Are Evolving Read Post »
By Joshua Mansour, M.D. Patients should have as much access to information as possible. The more they know, the more
Are Headlines of Medical Breakthroughs Overstating Actual Science and Research? Read Post »
For readers following the the Biologic Patent Transparency Act, DrugPatentWatch has recently been cited in an article describing the act as “A Solution in Search of a Problem.” In his article,…
The post DrugPatentWatch in the news: The Biologic Patent …
DrugPatentWatch in the news: The Biologic Patent Transparency Act. Read Post »
This paper was originally published by Reed F. Beall, Jason W. Nickerson, Warren A. Kaplan, Amir Attaran in PLoS ONE 11(2): e0148939 under a Creative Commons Attribution License. Abstract Background…
The post Is Patent “Evergreening” Restricting Access…
Is Patent “Evergreening” Restricting Access to Medicine/Device Combination Products? Read Post »
Healthcare systems including hospitals are taking care-related and business-related steps to cope with rapidly increasing drug prices.
The post Rising Drug Prices: How Healthcare Systems Are Coping appeared first on DrugPatentWatch – Make Better Decisi…
Rising Drug Prices: How Healthcare Systems Are Coping Read Post »
ANDA Litigation: Strategies and Tactics for Pharmaceutical Patent Litigators Kenneth L. Dorsney, Editor-in-Chief 985 pages (4 pounds!) Buy from Amazon A key component of the commercial and regulatory structure of…
The post ANDA Litigation: Strategies a…
ANDA Litigation: Strategies and Tactics for Pharmaceutical Patent Litigators Read Post »
Information contained in expired drug patents can be invaluable to researchers developing new products, but caution is required to avoid legal problems.
The post How Companies Can Extract Value from Expired Drug Patents appeared first on DrugPatentWatc…
How Companies Can Extract Value from Expired Drug Patents Read Post »
Get new actionable insights and updates from BiotechBlog
